Seeking Alpha

Complete Genomics (GNOM +2.3%) rejects Illumina's (ILMN) $114M bid despite the $3.30/share offer...

Complete Genomics (GNOM +2.3%) rejects Illumina's (ILMN) $114M bid despite the $3.30/share offer exceeding a $3.15 agreed proposal from China's BGI-Shenzhen. Illumina's bid is also not dependent on funding, nor is it subject to government approval as a foreign investment. Illumina "cannot comprehend" how GNOM "could rationally come to the conclusion" Illumina's offer is not superior. GNOM's shareholders may well agree.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)